Section 12-280-502 - Therapeutic interchange and therapeutically equivalent selections for nursing care facility or long-term acute care hospital patients - rules(1) A pharmacy used by a nursing care facility or a long-term acute care hospital licensed under part 1 of article 3 of title 25 may make a therapeutic interchange or a therapeutically equivalent selection for a patient if, during the patient's stay at the facility, the selection has been approved for the patient: (a) In accordance with written guidelines and procedures for making therapeutic interchange or therapeutically equivalent selections, as maintained in a current and readily available manner at the dispensing prescription drug outlet and as developed by a quality assessment and assurance committee that includes a pharmacist licensed under this article 280 and is formed by the facility in accordance with 42 CFR 483.75; and(b) By one of the following health-care providers:(I) A physician licensed under article 240 of this title 12;(II) A physician assistant licensed under section 12-240-113; or(III) An advanced practice registered nurse prescriber licensed as a professional nurse under section 12-255-110, registered as an advanced practice registered nurse under section 12-255-111, and authorized to prescribe controlled substances or prescription drugs pursuant to section 12-255-112.(2) The board may adopt rules as necessary to implement this part 5.Amended by 2023 Ch. 114,§ 7, eff. 8/7/2023.Amended by 2020 Ch. 190, § 31, eff. 7/1/2020.Renumbered from C.R.S. § 12-42.5-502 and amended by 2019 Ch. 136, § 1, eff. 10/1/2019.Added by 2015 Ch. 289, § 2, eff. 6/5/2015.L. 2015: Entire part added, (SB 15-192), ch. 289, p. 1185, § 2, effective June 5.This section is similar to former § 12-42.5-502 as it existed prior to 2019.
2023 Ch. 114, was passed without a safety clause. See Colo. Const. art. V, § 1(3). For the legislative declaration in HB 20-1216, see section 1 of chapter 190, Session Laws of Colorado 2020.